跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,892 条关于
“NAV-242”
全部
4,892
临床试验
2,968
药物
1,453
机构
55
资讯
416
去年
Navigator Medicines Reports Positive Phase 1a Safety Data for Dual-Target Bispecific Antibody NAV-240
去年
Boston Scientific's Farapulse System Gains FDA Nod for Enhanced Cardiac Mapping
11个月前
Frontier Medicines Unveils FMC-242, Novel PI3Kα/RAS Inhibitor Targeting Cancer's Most Common Genetic Drivers
7个月前
Grünenthal Initiates Phase I Trial of Novel NaV 1.8 Inhibitor for Non-Opioid Pain Management
去年
Navigator Medicines Initiates Phase 1b Trial of NAV-240 Bispecific Antibody for Autoimmune Diseases
去年
FDA Approves Boston Scientific's Next-Gen Pulsed Field Ablation Catheter for Paroxysmal Atrial Fibrillation
9个月前
Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in Rare Epileptic Encephalopathies
去年
Praxis Precision Medicines Advances Pipeline with Relutrigine into Late-Stage Development
去年
Praxis Precision Medicines Presents Promising Epilepsy Pipeline Updates at AES 2024
去年
Lantheus Advances Dual Alzheimer's Diagnostic Strategy with Tau and Beta-Amyloid PET Imaging Agents
第 1 页,共 42 页
上一页
下一页